FIVE PRIME THERAPEUTICS INC Intellectual Property Contracts & Agreements

26 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Zai Lab (Shanghai) Co., Ltd.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2018
Non-Exclusive License Agreement between National Research Council of Canada and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Technology License Agreement between National Research Council of Canada and Five Prime Therapeutics Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Non-Exclusive License Agreement between Stanford University and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Exclusive License Agreement between The Regents of the University of California and Five Prime Therapeutics, Inc. for Fibroblast Growth Factor Receptors
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Exclusive License Agreement between The Regents of the University of California and Five Prime Therapeutics, Inc. for Fibroblast Growth Factor Receptors
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Amendment No. 4 to Non-Exclusive License Agreement among Five Prime Therapeutics, BioWa, and Lonza
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 3 to Non-Exclusive License Agreement among Lonza Sales AG, BioWa, Inc., and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 2 to Non-Exclusive License Agreement among BioWa, Inc., Lonza Sales AG, and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 1 to Non-Exclusive License Agreement between Lonza Sales AG, BioWa, Inc., and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 2 to Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Amendment to Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC (May 16, 2016)
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2016
Amendment No. 3 to Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2016
Amendment No. 2 to Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2016
Research Collaboration and License Agreement between Five Prime Therapeutics, Inc. and INBRX 110 LP
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2015
Amendment No. 1 to Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Research Collaboration and License Agreement between Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Amending Agreement to Technology License between National Research Council of Canada and Five Prime Therapeutics Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amendment No. 1 to License Agreement between Stanford University and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Non-Exclusive License Agreement between BioWa, Inc., Lonza Sales AG, and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
IA
2013
Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC (December 22, 2011)
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC (December 22, 2011)
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013